These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6105443)

  • 21. [Immunosuppressive treatment of Crohn's disease].
    Kasper H; Auer I
    Dtsch Z Verdau Stoffwechselkr; 1976; 36(3-4):143-5. PubMed ID: 1021382
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A; George J; Sachar DB
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myelotoxicity due to interaction between azathioprine and allopurinol in a patient with Crohn's disease].
    Millán M; Castro-Fernández M; Ampuero J; Romero-Gómez M
    Gastroenterol Hepatol; 2013 Apr; 36(4):298-9. PubMed ID: 23274032
    [No Abstract]   [Full Text] [Related]  

  • 24. Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.
    Ochsenkühn T; Göke B; Sackmann M
    Am J Gastroenterol; 2002 Aug; 97(8):2022-5. PubMed ID: 12190171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Terdiman JP; Gruss CB; Heidelbaugh JJ; Sultan S; Falck-Ytter YT;
    Gastroenterology; 2013 Dec; 145(6):1459-63. PubMed ID: 24267474
    [No Abstract]   [Full Text] [Related]  

  • 27. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Dassopoulos T; Sultan S; Falck-Ytter YT; Inadomi JM; Hanauer SB
    Gastroenterology; 2013 Dec; 145(6):1464-78.e1-5. PubMed ID: 24267475
    [No Abstract]   [Full Text] [Related]  

  • 28. Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.
    Lennard-Jones JE
    Dig Dis Sci; 1981 Apr; 26(4):364-8. PubMed ID: 7016483
    [No Abstract]   [Full Text] [Related]  

  • 29. Maintenance treatment for Crohn's disease: has the time arrived?
    Goldstein F
    Am J Gastroenterol; 1992 May; 87(5):551-6. PubMed ID: 1350706
    [No Abstract]   [Full Text] [Related]  

  • 30. Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA.
    Haveran LA; Sehgal R; Poritz LS; McKenna KJ; Stewart DB; Koltun WA
    Dis Colon Rectum; 2011 Jan; 54(1):15-20. PubMed ID: 21160308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Invasive cancer of the cervix in a patient undergoing chronic treatment with 6-mercaptopurine for Crohns disease].
    Alvarez Delgado A; Pérez García ML; Fradejas Salazar PM; de la Coba Ortíz C; Rodríguez Pérez A
    Gastroenterol Hepatol; 2003 Jan; 26(1):52-3. PubMed ID: 12525330
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Crohn's disease].
    Vavricka SR; Rogler G
    Praxis (Bern 1994); 2009 Jan; 98(2):77-81. PubMed ID: 19153955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum sickness associated with 6-mercaptopurine in a patient with Crohn's disease.
    Andersen JM; Tiede JJ
    Pharmacotherapy; 1997; 17(1):173-6. PubMed ID: 9017780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.
    Allorge D; Hamdan R; Broly F; Libersa C; Colombel JF
    Gut; 2005 Apr; 54(4):565. PubMed ID: 15753546
    [No Abstract]   [Full Text] [Related]  

  • 35. Azathioprine, 6-mercaptopurine and thiopurine S-methyltransferase.
    Roberts-Thomson IC; Butler WJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):955. PubMed ID: 15946151
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease.
    Ananthakrishnan AN; Attila T; Otterson MF; Lipchik RJ; Massey BT; Komorowski RA; Binion DG
    J Clin Gastroenterol; 2007 Aug; 41(7):682-8. PubMed ID: 17667053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease.
    Mutinga M; Castells M; Horan R; Farraye FA
    Am J Gastroenterol; 2000 May; 95(5):1383-4. PubMed ID: 10811376
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
    Su C; Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.